Equitec Specialists’s Allergan plc AGN Stock Holding History

Equitec Specialists’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,200	Closed	-$2.21M	–	168
2019 Q2	$2.21M	Buy	+13,200	New	+$1.83M	0.58%	36

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Equitec Specialists's AGN Position: Q3 2019 in Review

Equitec Specialists sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 13,200 shares — an estimated $2.21M sold.

Equitec Specialists first reported a position in AGN in Q2 2019 and held it in 1 quarter. The position peaked at $2.21M in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

Equitec Specialists reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
Equitec Specialists sold 13,200 Allergan plc shares in Q3 2019, an estimated $2.21M.
Equitec Specialists first reported a position in Allergan plc in Q2 2019 and held it in 1 quarter.
Equitec Specialists's Allergan plc position peaked at $2.21M in Q2 2019.
921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Equitec Specialists's 13F filing for Q3 2019, filed 29 Oct 2019.